Can-Fite BioPharma (CANF) Net Margin Growth (3y) (2018 - 2023)
Can-Fite BioPharma (CANF) Net Margin Growth (3y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 9,934.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 31,387.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -5,319.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -11,156.00 |
| 10 | Can-Fite BioPharma | 2.82 Mn | -8.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.55 Mn |
| Sep 30, 2023 | 875,226.00 |
| Jun 30, 2023 | -827,281.00 |
| Mar 31, 2023 | 89,191.00 |
| Dec 31, 2022 | -1.06 Mn |
| Sep 30, 2022 | -151,718.00 |
| Jun 30, 2022 | 56,679.00 |
| Mar 31, 2022 | -171,307.00 |
| Dec 31, 2021 | 7,266.00 |
| Sep 30, 2021 | -542,267.00 |
| Jun 30, 2021 | 105,444.00 |
| Mar 31, 2021 | -99,661.00 |
| Dec 31, 2020 | 814,369.00 |
| Sep 30, 2020 | -991,083.00 |
| Jun 30, 2020 | -75,147.00 |
| Mar 31, 2020 | 33,354.00 |
| Dec 31, 2019 | 4.14 Mn |
| Sep 30, 2019 | -345,243.00 |
| Jun 30, 2019 | -412,964.00 |
| Mar 31, 2019 | -216,372.00 |